WCT EVI MAP Mapping the Evidence for the WHO Classification of Tumours: a Living Evidence Gap Map by Tumour Type.
- Coordinator
- Centre International De Recherche Sur Le Cancer, France
- Runs
- 1 July 2022 to 30 June 2026
- Status
- Running
- EU funding
- €2.8m
- Total cost
- €2.8m
- Partners
- 11 organisations in 6 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101057127
What the project is doing
In the project's own words, from its summary on CORDIS.
The WHO Classification of Tumours (WCT) underpins cancer diagnosis, and hence treatment and care of cancer patients, as well as research into cancer epidemiology, prevention, diagnosis, and treatment. However, decisions for such a global reference tool are not always informed by the best available evidence, and risks of incorporating misinformation into the clinical decisions pathway exist. We aim to develop a tool that maps existing evidence, showing gaps, identifying pockets of low-level evidence, and synthesis of reliable evidence.
The tool will map the evidence base of the WCT in order to facilitate evidence-based decision-making in pathology, and promote the application of higher research standards in the field. We will adapt the recently developed Evidence Gap Map (EGM) methodology, first time ever to be used in biomedicine. The resulting EGMs will increase the discoverability and use of studies by the WCT decision-makers, research commissioners, researchers and others.
Our WCT-EVI-MAP project is organized in three subsequent phases, where we will apply a stepwise approach to: first, develop a framework and define evidence levels based on expert consensus; second, elaborate a series of Megamaps in iterative cycles describing evidence of all tumour types; third, perform a descriptive analysis of the use of evidence in a continuous updated exercise. To overcome identified challenges, several strategies are proposed, such as using recent advances in technologies, following a strict multidisciplinary approach and integrating this project into the WCT strategic planning for the 6th edition.
We believe that the WCT EVI-MAP will represent a ground-breaking advance for the WCT and research in the field, and will accelerate progress in cancer diagnosis and management. Integration of evidence-based medicine methods has been shown to have a positive impact in other specialized medical fields and our project represents a first step towards an evidence-based pathology.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Centre International De Recherche Sur Le Cancer | Lyon 7eme | France | Coordinator |
| Deutsches Herzzentrum Munchen | Munich | Germany | Participant |
| Instituto De Salud Carlos Iii | Madrid | Spain | Participant |
| Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie -Panstwowy Instytut Badawczy | Warszawa | Poland | Participant |
| Singapore Breast Surgery Center Pte. Ltd. | Singapore | SG | Associatedpartner |
| Singapore General Hospital | Singapore | SG | Associatedpartner |
| The Chancellor, Masters and Scholars of the University of Oxford | Oxford | United Kingdom | Associatedpartner |
| The University of Birmingham | Birmingham | United Kingdom | Associatedpartner |
| The University of Sheffield | Sheffield | United Kingdom | Associatedpartner |
| University of Newcastle Upon Tyne | Newcastle Upon Tyne | United Kingdom | Associatedpartner |
| University of Plymouth | Plymouth | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI